Cargando…

Increased serum levels of TGFβ1 in children with localized scleroderma

BACKGROUND: There are neither sensitive nor specific laboratory tests for measuring disease activity in localized scleroderma (LS). Monitoring is done almost exclusively by clinical assessment. Our aim was to determine whether serum concentrations of TGFβ1 are a good biomarker of disease activity in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uziel, Yosef, Feldman, Brian M, Krafchik, Bernice R, Laxer, Ronald M, Yeung, Rae SM
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233624/ https://www.ncbi.nlm.nih.gov/pubmed/18053185 http://dx.doi.org/10.1186/1546-0096-5-22

Ejemplares similares

Scar wars: is TGFβ the phantom menace in scleroderma?
por: Leask, Andrew
Publicado: (2006)

Paclitaxel Modulates TGFβ Signaling in Scleroderma Skin Grafts in Immunodeficient Mice
por: Liu, Xialin, et al.
Publicado: (2005)

Evaluation of serum concentrations of the selected cytokines in patients with localized scleroderma
por: Budzyńska-Włodarczyk, Jolanta, et al.
Publicado: (2016)

Phototherapy in Scleroderma
por: Hassani, John, et al.
Publicado: (2016)

Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin
por: Nikitorowicz-Buniak, Joanna, et al.
Publicado: (2015)

Developing juvenile localized scleroderma (jLS) consensus treatment regimens for comparative effectiveness studies
por: Li, Suzanne C, et al.
Publicado: (2012)

Immunopathogenesis of Pediatric Localized Scleroderma
por: Torok, Kathryn S., et al.
Publicado: (2019)

Brain cavernomas associated with en coup de sabre linear scleroderma: Two case reports
por: Fain, Emily T, et al.
Publicado: (2011)

Alveolar macrophages in scleroderma lung disease are activated by TGF-β and IL-4 but not TNF-α
por: Luzina, I, et al.
Publicado: (2003)

Cross-talk between TRAIL and TGF-β in regulation of collagen production in scleroderma lung disease
por: Yurovsky, VV
Publicado: (2004)

Dual mTOR Inhibition Is Required to Prevent TGF-β-Mediated Fibrosis: Implications for Scleroderma
por: Mitra, Anupam, et al.
Publicado: (2015)

Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study
por: Li, Suzanne C., et al.
Publicado: (2019)

An Update on Childhood-Onset Takayasu Arteritis
por: Aeschlimann, Florence A., et al.
Publicado: (2022)

Surgical Management of Localized Scleroderma
por: Lee, Jae Hyun, et al.
Publicado: (2017)

Arterial dissection in childhood Takayasu Arteritis: not as rare as thought
por: Aeschlimann, Florence A., et al.
Publicado: (2016)

A Toddler Presenting with Pulmonary Renal Syndrome
por: Aeschlimann, Florence A., et al.
Publicado: (2017)

Serum Homocystein Level in Patients With Scleroderma
por: Nazarinia, Mohammadali, et al.
Publicado: (2013)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts
por: Man, Xiao-Yong, et al.
Publicado: (2012)

Description of the localized scleroderma subgroup of CARRAnet
por: Wu, Eveline, et al.
Publicado: (2012)

Periostin in Mature Stage Localized Scleroderma
por: Kim, Min-Woo, et al.
Publicado: (2017)

Hyaluronic Acid Filler Injection for Localized Scleroderma – Case Report and Review of Literature on Filler Injections for Localized Scleroderma
por: Sharad, Jaishree
Publicado: (2022)

JUVENILE LOCALIZED SCLERODERMA WITH AUTOIMMUNE THYROID DISORDER
por: Hiremath, N C, et al.
Publicado: (2010)

The Transcriptional Cofactor Nab2 Is Induced by TGF-β and Suppresses Fibroblast Activation: Physiological Roles and Impaired Expression in Scleroderma
por: Bhattacharyya, Swati, et al.
Publicado: (2009)

Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor
por: Liakouli, Vasiliki, et al.
Publicado: (2018)

Juvenile localized scleroderma: review of 44 patients
por: Iglesias, E, et al.
Publicado: (2011)

Parry-Romberg Syndrome Associated with Localized Scleroderma
por: Maletic, Jelena, et al.
Publicado: (2010)

Localized Scleroderma Associated with Chronic Hepatitis C
por: de Oliveira, Felipe Ladeira, et al.
Publicado: (2012)

Localized scleroderma: clinical spectrum and therapeutic update()
por: Careta, Mariana Figueiroa, et al.
Publicado: (2015)

Evaluation of mean platelet volume in localized scleroderma
por: Bahali, Anil Gulsel, et al.
Publicado: (2017)

Update on Management of Morphea (Localized Scleroderma) in Children
por: George, Renu, et al.
Publicado: (2020)

Connective tissue nevus misdiagnosed as juvenile localized scleroderma
por: Tirelli, F., et al.
Publicado: (2023)

Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib
por: Wang, Dandan, et al.
Publicado: (2023)

Development of neoplasms in pediatric patients with rheumatic disease exposed to anti-tumor necrosis factor therapies: a single Centre retrospective study
por: Okihiro, Alexandra, et al.
Publicado: (2018)

Scleroderma Adultorum
por: M'Calman, Dove
Publicado: (1881)

Scleroderma
Publicado: (1890)

Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
por: Macklin, Michael, et al.
Publicado: (2023)

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
por: Martini, G, et al.
Publicado: (2008)

Efficacy and safety of methotrexate treatment of juvenile localized scleroderma
por: Osminina, MK, et al.
Publicado: (2008)

Long-term methotrexate efficacy in juvenile localized scleroderma
por: Zulian, F, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bs5gt2p1vm9t00ja7fqbnomd0d